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High-fat diet-induced obesity 
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Abstract 
Background: Obesity has deleterious effects on the brain, and metabolic dysfunction may exacerbate the outcomes 
of seizures and brain injuries. However, it is unclear whether obesity affects excitotoxicity‑induced neuronal cell death. 
The purpose of this study was to investigate the effects of a high‑fat diet (HFD) on neuroinflammation and oxidative 
stress in the hippocampus of kainic acid (KA)‑treated mice.
Results: Mice were fed with a HFD or normal diet for 8 weeks and then received a systemic injection of KA. HFD‑fed 
mice showed hypercholesterolemia, insulin resistance, and hepatic steatosis. HFD‑fed mice showed greater suscep‑
tibility to KA‑induced seizures, an increased number of terminal deoxynucleotidyl transferase dUTP nick end labeling 
(TUNEL)‑positive cells, neuroinflammation, and oxidative stress. Furthermore, we found that KA treatment increased 
HFD‑induced calpain1, nuclear factor E2‑related factor 2, and heme oxygenase‑1 expression in the hippocampus.
Conclusions: These findings imply that complex mechanisms affected by obesity‑induced systemic inflammation, 
neuroinflammation, ER stress, calcium overload, and oxidative stress may contribute to neuronal death after brain 
injury.
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Background
Patients with epilepsy have a greater risk for obesity than 
the general population due to treatment of anti-epi-
leptic medications [1, 2], and obesity is also a common 
comorbidity in children with untreated epilepsy [3, 4]. 
Although metabolic dysfunction is known to modulate 
the outcome of brain injury and increase seizure sever-
ity [5], it remains unclear the molecular mechanisms 
that metabolic dysfunction causes excitotoxicity-induced 
neuronal death. However, accumulating evidence sug-
gests that metabolic dysfunction could have a deleterious 
effect on excitotoxicity-induced neuronal death. Spe-
cifically, a high-fat diet (HFD) is associated with brain 
insulin resistance and compromised synaptic integrity 
[6]. Adiponectin-deficient mice exhibit insulin resistance, 
hyperlipidemia, and inflammation [5, 7], and adiponec-
tin-deficient mice fed a HFD display increased seizure 
severity, whereas injection of adiponectin reduces kainic 
acid (KA)-induced excitotoxicity [5, 8]. Furthermore, the 
neurotoxins methamphetamine and KA increase mortal-
ity and neurodegeneration in ob/ob mice more than in 
lean mice [9].
KA-induced hippocampal changes are associated 
with blood-brain barrier (BBB) leakage, astrogliosis, 
inflammation, oxidative stress, calcium overload, apop-
tosis, and endoplasmic reticulum (ER) stress [10–13]. 
Nuclear factor-kappaB (NF-κB)-mediated neuroinflam-
mation is induced by seizures and increases suscep-
tibility to excitotoxicity-induced neuronal cell death 
[14]. In particular, the nuclear factor E2-related factor 2 
(Nrf2)-mediated defense pathway is involved in neuronal 
sensitivity to KA [15], and activation of this pathway 
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exerts neuroprotective effects by elevating antioxidant 
enzymes [16]. For example, Nrf2 plays an important role 
in protecting hepatocytes from hepatic steatosis in HFD-
fed mice [17]. Obesity-induced mitochondrial dysfunc-
tion and oxidative stress also contribute to the initiation 
and progression of seizures [9]. In our previous study, 
we showed that an ER stress inhibitor attenuates KA-
induced hippocampal cell death [13]. However, to our 
knowledge, whether the Nrf2-mediated antioxidant path-
way plays a role in KA-induced brain injury in HFD-fed 
mice has not been studied.
Therefore, the aim of the present study was to deter-
mine whether chronic HFD-induced obesity contributes 
to deleterious effects of KA treatment on the hippocam-
pus and to investigate several mechanisms including 
inflammation and oxidative stress between metabolic 
dysfunction and neuronal injury. We also examined 
whether obesity-induced systemic inflammation exac-
erbates the inflammatory changes induced by KA 
treatment.
Results
Effect of a HFD on obesity‑related phenotypes and insulin 
resistance
Mice were fed with a normal diet (ND) or HFD for 
8 weeks. HFD mice had heavier body weights, livers and 
epididymal fat pads than ND mice (Additional file 1: Fig. 
S1A–D). H&E staining revealed that HFD mice had dis-
tended hepatocytes with accumulated fat and epididy-
mal fat pads with the presence of many macrophages 
(Additional file  1: Fig.  S1E). HFD mice also had higher 
levels of hepatic triglyceride (TG) than ND mice (Addi-
tional file 1: Fig. S1F). To confirm whether a HFD causes 
metabolic dysfunction, we measured levels of serum 
lipid metabolic factors and hepatic enzymes. HFD mice 
displayed elevated levels of serum free fatty acid (FFA), 
aspartate aminotransferase (AST), alanine aminotrans-
ferase (ALT), total cholesterol, and TG (Additional file 2: 
Table S1).
To confirm the effect of a HFD on insulin resistance, 
we measured blood glucose and serum insulin level, and 
performed glucose tolerance test (GTT) and insulin tol-
erance test (ITT) (Additional file  3: Fig.  S2A–D). After 
4  weeks, HFD mice were more glucose tolerant than 
ND mice (Additional file 3: Fig. S2A). HFD mice showed 
hyperinsulinemia and a greater increase in glucose lev-
els than ND mice during an ITT and a GTT (Additional 
file  3: Fig.  S2B–D). HFD mice also exhibited hypoadi-
ponectinemia (Additional file 3: Fig. S2E) and increased 
serum levels of interleukin-6 (IL-6) and tumor necro-
sis factor (TNF)-α compared with ND mice (Additional 
file 3: Fig. S2F, G).
Effect of a HFD on KA‑induced seizure activity 
and mortality
We next examined whether a HFD affects KA-induced 
seizure severity. HFD mice showed more severe seizure 
behaviors than ND mice, showing stretching of the body, 
tail straightening, and bulging eyes during the first 5 min 
after KA injection (Fig.  1a). To further evaluate seizure 
activity, we performed electroencephalographic (EEG) 
recordings. HFD mice showed a characteristic pattern 
of more spontaneous seizure activity within 5 min after 
KA treatment (Fig. 1b), and HFD + KA mice exhibited a 
higher number and longer duration of seizure spike trains 
than ND + KA mice (Fig. 1c). HFD + KA mice also dis-
played lower survival rates than ND + KA mice (Fig. 1d).
Effects of a HFD on KA‑induced hippocampal cell death
Upon examination of cresyl violet-stained sections, we 
found more pyknotic nuclei, typically found in apoptotic 
cells, in the CA3 region of ND  +  KA and HFD  +  KA 
mice (Fig.  2a). To confirm that KA induced neuronal 
death, we performed Terminal deoxynucleotidyl trans-
ferase dUTP nick end labeling (TUNEL) staining 
(Fig. 2b). Both ND + KA and HFD + KA mice showed 
a dramatic increase in TUNEL-positive cells in the hip-
pocampus. HFD +  KA mice (22.4 ±  1.5) showed more 
TUNEL-positive cells than ND +  KA mice (19.3 ±  0.8, 
P < 0.05).
Together, these results indicate that HFD exacerbates 
KA-induced neuronal death. To investigate whether KA 
affects calcium-mediated cell death in HFD-fed mice, 
we performed immunohistochemistry with hippocal-
cin and western blot analysis with calpain1, a calcium-
dependent protease. Double immunostaining showed a 
lack of hippocalcin-positive calcium-buffering neurons 
(NeuN-positive) in the hippocampus of both ND + KA 
and HFD +  KA mice (Fig.  3a). We found that calpain1 
expression was increased in ND  +  KA-and HFD mice 
compared with ND mice, and a HFD augmented the KA-
induced increase in calpain1 expression (Fig. 3b).
Effects of a HFD on KA‑induced neuroinflammation
Previous studies show that KA treatment induces neu-
roinflammation and microglial activation through high 
mobility group box 1 (HMGB1) and its receptor, toll-
like receptor 4 (TLR4) [18, 19]. We confirmed that KA 
treatment increased hippocampal HMGB1 and TLR4 
expression (Fig.  4a, b). We also showed that a HFD in 
the absence of KA treatment also increased hippocam-
pal HMGB1 and TLR4 expression. Then, we examined 
iba-1 immunoreactivity and found that the increased 
labeling in the CA3 region of ND + KA mice and even 
greater labeling in the CA3 region of HFD +  KA mice 
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(Fig.  4c). Consistent with these results, western blot 
analysis showed that a HFD significantly increased 
the KA-induced expression of iba-1 protein (Fig.  4d). 
We also observed an upregulation of hippocampal 
cyclooxygenase-2 (COX-2) expression in ND  +  KA, 
HFD, and HFD + KA mice compared with ND-fed mice 
(Additional file 4: Fig. S3A). However, there was no sig-
nificant change in both ND + KA and HFD + KA mice. 
Fig. 1 Effects of a HFD on KA‑induced seizure activity and mortality. a Seizure behavior scores for ND + KA and HFD + KA mice. Scores were 
recorded every 5 or 10 min. b EEG recording within 5 min of a spontaneous seizure in ND + KA and HFD + KA mice. c Quantification of EEG 
recordings during 4 h after KA injection in ND + KA and HFD + KA mice (n = 3 mice per group). d Percentage of ND + KA and HFD + KA mice that 
survived for 24 h after KA injection. Data are shown as mean ± SEM. *p < 0.05 for HFD + KA mice versus ND + KA mice
Fig. 2 Effects of a HFD on KA‑induced hippocampal cell death and calcium overload. Representative microphotographs of cresyl violet staining (a) 
and TUNEL staining (b) in the CA3 region of ND, ND + KA, HFD, and HFD + KA mice. Scale bar 50 μm
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Immunohistochemistry revealed intense COX-2-stain-
ing in the dentate gyrus (DG) and CA3 regions after KA 
treatment, particularly in HFD  +  KA mice (Additional 
file  4: Fig.  S3B). Additionally, we also found inducible 
nitric oxide synthase (iNOS) expression is increased in 
the hippocampus of ND  +  KA, HFD, and HFD  +  KA 
mice compared with ND-fed mice (Additional file  4: 
Fig. S3C).
Effects of a HFD on KA‑induced ER stress and Nrf2/HO‑1 
defense pathway
The ER response involving protein kinase RNA-like ER 
kinase (PERK) and its downstream activating transcrip-
tion factor4 (ATF4) are essential for ER stress-induced 
apoptosis [20]. To examine whether HFD alters expres-
sion of ER stress-induced proteins in the hippocampus 
after KA treatment, we performed western blot analysis. 
We found that both KA treatment and a HFD increased 
PERK and ATF4 expression (Additional file 5: Fig. S4A). 
These results suggest that HFD contributes to KA-
induced neuronal death by increasing ER stress signaling, 
particularly the PERK-ATF4 pathway. In addition, con-
sistent with an increase in ER stress, we found that both 
KA treatment and a HFD increased 4-hydroxynonenal 
(4-HNE) expression (Additional file 5: Fig. S4B).
Nrf2 signaling plays an important role in protec-
tion against brain injury [21]. Therefore, we examined 
whether a HFD affects hippocampal Nrf2 expression in 
response to KA treatment using western blot analysis and 
double immunofluorescence staining. Western blot anal-
ysis showed that Nrf2 expression was increased in HFD 
and HFD + KA mice compared with ND mice (Fig. 5a). 
We also observed that KA-treated mice showed a dra-
matic increase of Nrf2 in the nucleus of NeuN-positive 
neurons (Fig. 5b). Activation of Nrf2 in response to brain 
injury may be dependent on the induction of antioxidant 
response element (ARE)-related genes [22]. Therefore, 
we assessed hippocampal heme oxygenase-1 (HO-1) and 
Fig. 3 Effects of a HFD on hippocalcin and calpain1 expression KA‑treated hippocampus. a Representative microphotographs of double immu‑
nofluorescence of hippocalcin and NeuN in the CA3 region of ND, ND + KA, HFD, and HFD + KA mice. Scale bar 50 μm. b Western blot analysis 
of calpain1. Densitometry values for each protein were normalized to α‑tubulin and expressed as fold change relative to the ND group. Data are 
shown as mean ± SEM (n = 4 mice per group). *p < 0.05 versus ND. #p < 0.05 versus HFD. †p < 0.05 versus ND + KA
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NAD(P)H:quinone oxidoreductase-1 (NQO1) expres-
sion using western blot analysis. ND + KA or HFD mice 
exhibited greater HO-1 and NQO1 expression than ND 
mice, and a HFD augmented the KA-induced increase in 
HO-1 and NQO1 expression (Fig.  5c; Additional file  5: 
Fig. S4C).
Discussion
HFD-induced chronic inflammation, mainly elicited 
by microglia in the brain, exacerbates pathologies by 
increasing production of reactive oxygen species (ROS) 
and proinflammatory cytokines. Our findings support 
previous observations that obesity is associated with sei-
zure susceptibility in children and that metabolic dys-
function, including insulin resistance, hepatic steatosis, 
and macrophage infiltration in adipose tissue, contrib-
utes to neuroinflammation and exacerbates KA-induced 
neuronal death [1–5]. Interestingly, HFD-induced cal-
pain1 expression was augmented by KA treatment and 
KA-induced hippocampal cell death was more prominent 
in HFD-fed mice than in ND-fed mice. Thus, we suggest 
that metabolic dysfunction-induced inflammation may 
augment KA-induced calcium overload, neuroinflamma-
tion, and oxidative stress and thereby contribute to neu-
ronal cell death.
Metabolic dysfunction, such as dyslipidemia, insulin 
resistance, and hepatic steatosis, can exacerbate seizure-
induced brain injury [7, 23], and conversely the use of 
common anti-epileptic drugs leads to weight gain and 
metabolic dysfunction [24]. In particular, a high-fat, 
low-carbohydrate ketogenic diet (KD), which is some-
times used to treat drug-resistant epilepsy, can lead to 
hepatic steatosis [18, 25]. In a previous study, KD-fed 
mice showed lower fasting blood glucose and homeo-
static model assessment of insulin resistance (HOMA-
IR) levels than mice fed standard chow and HFD-fed 
mice showed higher glucose and HOMA-IR levels than 
KD-fed mice [26]. Taken together, these findings suggest 
Fig. 4 Effects of a HFD on KA‑induced neuroinflammation. Western blot analysis of HMGB1 (a) and TRL4 (b). Densitometry values for each protein 
were normalized to β‑actin and expressed as fold change relative to the ND group. c Representative immunofluorescence images of iba‑1 in the 
CA3 region after KA treatment. Scale bar 50 µm. a ND; b ND + KA; c HFD; d HFD + KA. d Western blot analysis of hippocampal iba‑1 levels after 
KA treatment. Densitometry values for iba‑1 were normalized to β‑actin and expressed as fold change relative to the ND group. Data are shown as 
mean ± SEM (n = 4 mice per group). *p < 0.05 versus ND. #p < 0.05 versus HFD. †p < 0.05 versus ND + KA
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that KD as a treatment for drug-resistant epilepsy does 
not affect insulin resistance but induces hepatic steato-
sis. Thus, obesity paired with anti-epileptic drugs or a KD 
may not exacerbate seizure-induced neuronal cell death, 
but chronic HFD-induced insulin resistance may bring 
other seizure-related outcomes such as neuroinflamma-
tion, ER stress, and ROS.
We found that mice fed a HFD diet for 8 weeks exhib-
ited obesity-related phenotypes and insulin resistance. 
Then, we tested whether HFD-induced obesity exacer-
bates seizures. Consistent with evidence that KA-induced 
neurotoxicity is exaggerated in ob/ob mice [9], we found 
that KA-treated HFD mice showed more severe seizures 
and greater mortality than KA-treated ND mice. Also, 
adiponectin deficiency, which is characteristic of obesity 
and diabetes, increases seizure sensitivity and neuronal 
loss in the KA-treated hippocampus [5]. Although adi-
ponectin deficiency alone without metabolic changes 
may not be sufficient to enhance seizure sensitivity, there 
is a strong positive correlation between seizure severity 
and insulin resistance in HFD mice [5]. We previously 
found that intracerebroventricular injection of recombi-
nant adiponectin protects against BBB breakdown and 
neuronal cell death [8]. In the present study, HFD mice 
had lower serum adiponectin levels than ND mice. These 
findings indicate that metabolic disturbances may exacer-
bate seizure-induced neuronal injury.
We found that KA-treated HFD mice exhibited more 
neuroinflammation than KA-treated ND mice. Specifi-
cally, hippocampal levels of the microglia marker iba-1 
were elevated in ND  +  KA mice and even further ele-
vated in HFD + KA mice. A HFD can cause peripheral 
Fig. 5 Effects of HFD on KA‑induced hippocampal Nrf2 and HO‑1 expression. a Western blot analysis of Nrf2. b Representative immunofluores‑
cence images of Nrf2 (red) and NeuN (green) in the hippocampus of ND and HFD mice with or without KA treatment. Scale bar 50 µm. c Western 
blot analysis of HO‑1 in the hippocampus of ND and HFD mice with or without KA treatment. Densitometry values for Nrf2 and HO‑1 were normal‑
ized to β‑actin and expressed as fold change relative to the ND group. Data are shown as mean ± SEM (n = 4 mice per group). *p < 0.05 versus ND. 
#p < 0.05 versus HFD. †p < 0.05 versus ND + KA
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and central inflammation and the induction of ROS in 
rodents [27]. We also found that a HFD increased lev-
els of the inflammatory cytokines IL-6 and TNF-α. As a 
recent study reports that KA treatment disrupts the BBB 
[14], we speculate that HFD-induced induction of inflam-
matory cytokines may exacerbate KA-induced inflamma-
tion through a breakdown of the BBB.
Levels of HMGB1 are increased in children with febrile 
seizures [28], and increased expression of HMGB1 con-
tributes to the generation and perpetuation of seizures 
in humans or mouse models of epilepsy [21]. Further-
more, antagonists of HMGB1 can decrease seizure recur-
rence [29]. Consistent with our previous study showing 
that KA treatment induces microglial activation through 
HMGB1 [14], we found increased HMGB1 and TLR4 
expression in the hippocampus of KA-treated mice with 
or without HFD and then KA-induced microglial activa-
tion was augmented by KA treatment. This data indicate 
that HFD-induced systemic inflammation may exacer-
bate KA-induced neuroinflammation through microglial 
activation.
Oxidative stress is an important factor contributing to 
excitotoxicity-induced brain injury. ROS enhances glu-
tamate release and expression of specific genes of lipid 
peroxidation and DNA oxidation resulting in neuronal 
death [30]. In a previous study, valproic acid, which is 
commonly used to treat epileptic seizures, reduced the 
number of TUNEL-, iba-1-, and 4-HNE-positive cells in 
rats with ischemic injury [31]. Consistently, higher levels 
of 4-HNE were found in the hippocampus of rats with 
soman-induced seizures [32], suggesting that increases in 
lipid peroxidation products might be due to excitotoxic-
ity-induced increases of NO-related reactive radicals in 
the KA-treated hippocampus. Alternatively, mild oxida-
tive stress induced by a KD may activate an Nrf2-medi-
ated antioxidant response, leading to a decrease in ROS 
production [33].
In addition to oxidative stress, KA treatment causes a 
persistent increase in intracellular Ca2+ and disruption of 
ER-mediated Ca2+ homeostasis in hippocampal neurons 
[34]. Our previous study demonstrates that an ER stress 
inhibitor attenuates KA-induced Ca2+ signaling and acti-
vation of the PERK-ATF4 pathway 6 h after KA treatment 
[13]. In the present study, we found that although both a 
HFD and KA treatment increased hippocampal levels of 
PERK and ATF4, their expressions in HFD-treated mice 
were not significantly increased by KA treatment. This 
data indicate that chronic HFD itself may contribute to 
ER stress in the brain.
Nrf2 participates in the modulation of microglia under 
conditions of lipopolysaccharide- or MPTP-induced neu-
roinflammation [35]. In the present study, we observed 
increased levels of Nrf2/HO-1 in the KA-treated 
hippocampus and even greater levels in the hippocam-
pus of HFD + KA-treated mice. In agreement with our 
results, a previous study showed higher Nrf2 mRNA lev-
els in the cerebral cortex of HFD mice compared with ND 
mice [26]. We found that in addition to elevated nuclear 
Nrf2 content, total Nrf2 was also increased in HFD + KA 
mice. A previous study reports that Nrf2 knockout mice 
display increased sensitivity to KA-induced seizures [15], 
suggesting that Nrf2 activation is an important defense 
against the deleterious outcomes of KA treatment. Simi-
lar to Nrf2 expression, we found that KA-induced HO-1 
and NQO1 expression was further increased by HFD, 
suggesting that activation of Nrf2/ARE may be a response 
to the seizure-induced brain damage. Mostly, both HO-1 
and NQO1 are considered as representative antioxidant 
proteins via Nrf2 signaling. Because mouse NQO1 pro-
moter gene contains an Nrf2-binding consensus regu-
latory sequence known as ARE [36]. A previous study 
suggests that inhibitor of HO-1 do not improve neuronal 
survival and increases mortality in KA-injected rats [37], 
but pretreatment with the anti-oxidant curcumin attenu-
ates KA-induced neuronal death by controlling HO-1 
expression [10]. However, our results suggest that acti-
vation of the Nrf2/HO-1/NQO1 pathway may respond 
to chronic HFD-induced oxidative stress and aggravate 
brain insults such as ischemia, trauma, and seizures. 
Thus, we suggest that Nrf2 is involved in regulating the 
expression of both HO-1 and NQO1 against KA-induced 
oxidative or inflammatory insults.
Conclusions
In conclusion, the results of this study suggest that com-
plex mechanisms affected by obesity-induced systemic 
inflammation, neuroinflammation, ER stress, calcium 
overload, and oxidative stress may contribute to neuronal 
death after brain injury.
Methods
Animals
Male ICR mice (5  weeks old) were purchased from 
KOATECH Co. (Pyeongtaek, South Korea) and main-
tained in the animal facility at Gyeongsang National 
University. All animal experiments were approved by 
the institutional review board at Gyeongsang National 
University and were performed in accordance with the 
National Institutes of Health guidelines for laboratory 
animal care. Mice were individually housed with a 12-h 
light/dark cycle and had free access to food pellets and 
tap water.
HFD and seizure induction
Mice were fed with either a normal laboratory chow 
diet (ND, 2018S; 18  kcal  % fat, 58  kcal  % carbohydrate, 
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and 24  kcal  % protein, Harlan Laboratories, Inc., Indi-
anapolis, IN, USA) or a HFD (D12079B; 60  kcal  % fat, 
20 kcal % carbohydrate, and 20 kcal % protein, Research 
Diets, New Brunswick, NJ, USA) ad libitum for 8 weeks 
and then received an intraperitoneal injection of 30 mg/
kg KA (Abcam, Cambridge, MA, USA) emulsified in 
0.9  % normal saline. Mice were divided randomly into 
four groups: ND (n =  14), HFD (n =  14), ND and KA 
injection (ND + KA, n = 20), or HFD and KA injection 
(HFD + KA, n =  20). Mice were monitored for seizure 
behavior for 2 h after KA injection. Seizure severity was 
assessed by a 6-point scale (I–VI) as previously described 
[38].
EEG recording
For EEG recordings of KA-induced seizures, we used 
a small animal radio telemetry system (Data Sciences 
International, St. Paul, MN, USA) to monitor brain elec-
trical activity in freely mobile ND + KA or HFD + KA 
mice. EEG recordings were performed after surgical 
implantation of telemetric transmitters (TA10EA-F20; 
Data Sciences International) using procedures adapted 
from those used in a previous study with similar equip-
ment [39]. Prior to surgery, mice were anesthetized 
with zoletil (0.5  mg/kg, Virbac Laboratories, Carros, 
France). EEG activity was monitored for 6 h as previously 
described [14]. To distinguish between abnormal interic-
tal spikes and physiologically occurring spikes in epidural 
one-channel EEG, we manually counted only spikes that 
were followed by a wave.
GTT and ITT
For the GTT, mice were fasted overnight (16 h) and then 
received an intraperitoneal injection of d-glucose (2 g/kg; 
Sigma-Aldrich, St. Louis, MO, USA). Blood samples were 
then collected from the tail vein. For the ITT, mice were 
given a intraperitoneal injection of insulin (0.75  U/kg, 
Humulin-R; Eli Lilly, Indianapolis, IN, USA), and blood 
glucose was measured using an Accu-Chek glucometer 
(Roche Diagnostics GmbH, Mannheim, Germany).
Tissue preparation and staining
For tissue analysis, mice were anesthetized with zoletil 
(5  mg/kg, Virbac Laboratories) and then perfused tran-
scardially with heparinized saline followed by 4 % para-
formaldehyde in 0.1 M phosphate-buffered saline (PBS). 
After post-fixation in the same fixative for 6  h, brains 
were sequentially immersed in PBS containing 15  % 
and then 30  % sucrose at 4  °C until they were com-
pletely submerged. Brains were cut into 40-μm thick 
coronal sections and stained with cresyl violet. Livers and 
epididymal fat pads were processed for paraffin embed-
ding, sectioned (5 µm), and stained with hematoxylin and 
eosin (H&E). Sections were visualized under a BX51 light 
microscope (Olympus, Tokyo, Japan), and digital images 
were captured.
Hepatic TG colorimetric assay
Frozen livers were freshly homogenized, and the super-
natants were used to determine TG levels. TG concentra-
tion (n =  6 mice per group) was measured using a TG 
colorimetric assay kit (Cayman Chemical Company, Ann 
Arbor, MI, USA).
Measurement of serum metabolic parameters
Mice were intramuscularly anesthetized with zoletil 
(5 mg/kg; Virbac Laboratories), and blood samples were 
extracted transcardially and allowed to clot for 2  h at 
room temperature. After centrifugation, serum samples 
were stored at −80  °C until analysis. Serum AST, ALT, 
FFA, total cholesterol, and TG levels were determined 
using enzymatic colorimetric assays (Green Cross Refer-
ence Laboratory, Yongin-si, South Korea). Serum insulin 
and adiponectin concentrations in ND and HFD mice 
(n = 8–10 mice per group) were measured using mouse 
insulin (Shibayagi Co., Gunma, Japan) and adiponec-
tin (Shibayagi) enzyme-linked immunosorbent assay 
(ELISA) kits, respectively. Serum IL-6 and TNF-α con-
centrations (n  =  8–10 mice per group) were measured 
using mouse IL-6 and TNF-α ELISA kits (R&D Systems, 
MN, USA), respectively.
TUNEL staining
TUNEL analysis was performed to measure the degree of 
apoptosis in tissue using an in situ cell death detection kit 
(Roche Molecular Biochemicals, Mannheim, Germany) 
according to the manufacturer’s protocol. Stained brain 
sections were visualized with a confocal microscope (FV-
1000, Olympus), and digital images were captured. For 
each treatment group, TUNEL-positive cells were manu-
ally counted in the CA3 region (50 × 50 µm) in three sec-
tions (n = 3 mice per group). The cells were counted by 
observers blinded to the treatment conditions using 20× 
objectives.
Immunofluorescence
For double immunofluorescence staining, frozen free-
floating brain sections were incubated with primary 
antibodies (Additional file  6: Table  S2); rabbit anti-hip-
pocalcin, mouse anti-NeuN, rabbit anti-Nrf2 at 4  °C for 
2  days. After washing three times with PBS, sections 
were incubated with Alexa Fluor 488- or 594-conjugated 
donkey anti-rabbit or anti-mouse antibody (Invitrogen, 
Carlsbad, CA, USA). Fluorescence was visualized with 
a confocal microscope (FV-1000, Olympus), and digital 
images were captured.
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Immunohistochemistry
Frozen free-floating brain sections were incubated with 
rabbit anti-COX-2 (Additional file 6: Table S2) overnight 
at 4 °C. After three washes with PBS, sections were incu-
bated for 1 h at room temperature with biotinylated sec-
ondary antibody. After washing three times with PBS, 
sections were incubated in avidin–biotin-peroxidase 
complex solution (Vector Laboratories, Burlingame, CA, 
USA). Sections were developed with 0.025  % diamin-
obenzidine (Sigma) containing 0.025  % H2O2, mounted 
on gelatin-coated slides, warm-dried, dehydrated 
through graded alcohols, cleared in xylene, and finally 
coverslipped with Permount (Sigma). Stained sections 
were visualized with a BX51 light microscope (Olympus), 
and digital images were captured.
Western blot analysis
After anesthesia with zoletil (5 mg/kg; Virbac Laborato-
ries), brains were quickly removed from skulls, and both 
hippocampi were dissected and frozen. Hippocampal 
whole cellular extracts and nuclear fractions were pre-
pared as previously described [38]. Frozen hippocampi 
were individually transferred to sterile 1.5-ml micro-
centrifuge tubes containing 200  µl lysis buffer (15  mM 
HEPES, pH 7.9, 0.25  M sucrose, 60  mM KCl, 10  mM 
NaCl, 1  mM EGTA, 1  mM PMSF, and 2  mM NaF). 
Homogenized tissue was incubated for 10  min on ice 
and then sonicated. Samples were then centrifuged at 
4  °C for 30  min at 12,000  rpm. The supernatants were 
transferred to clean vials and stored at −80 °C. The pro-
tein concentration of each lysate was determined using 
a bicinchoninic acid kit (Pierce, Rockford, IL, USA) 
according to the manufacturer’s protocol, using bovine 
serum albumin as a standard. Equal amounts of protein 
(30 μg) were separated by SDS-PAGE and transferred to 
nitrocellulose membranes. The membranes were washed 
in Tris-buffered saline containing 0.5  % Tween-20 and 
incubated with the following primary antibodies (Addi-
tional file  6: Table  S2): iba-1, HMGB1, TLR4, 4-HNE, 
PERK, ATF4, HO-1, NQO1, COX-2, or iNOS. Samples 
were then incubated with their corresponding secondary 
antibodies. The enhanced chemiluminescence western 
blot analysis system (Amersham Pharmacia Biotech, Pis-
cataway, NJ, USA) was used for detection. To normalize 
protein levels, α-tubulin or β-actin was used as an inter-
nal control.
Statistical analysis
Differences among experimental groups were determined 
using one-way analysis of variance (ANOVA) followed by 
post hoc analysis with Student–Newman–Keuls tests. 
Student’s t-tests were used for comparisons between two 
groups. Values are expressed as mean ±  standard error 
of the mean (SEM). Statistical significance was set at 
p < 0.05.
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Additional file 1: Figure S1. Effects of a HFD on obesity‑related pheno‑
types. Body weight (A) and external phenotype (B); liver and epididymal 
fat pad weight (C), gross appearance (D), and representative H&E staining 
(E) in liver and epididymal fat; and levels of hepatic TG (F) were assessed 
in mice fed a ND or HFD for 8 weeks. Data are presented as mean ± SEM 
(n = 8‑10 mice per group). *p < 0.05 for HFD mice versus ND mice. Scale 
bar = 1 cm (B and D), 100 μm (E).
Additional file 2: Table S1. Effects of a HFD on serum metabolic 
parameters.
Additional file 3: Figure S2. Effects of a HFD on insulin resistance. 
Fasting blood glucose (A) in mice fed a ND or HFD for 8 weeks. Serum 
insulin levels (B), glucose levels in ITTs (C) and GTTs (D), adiponectin (E), 
IL‑6 (F), and TNF‑α (G) were measured in mice fed a ND or HFD. Data are 
presented as mean ± SEM (n = 8‑10 mice per group). *p < 0.05 for HFD 
mice versus ND mice.
Additional file 4: Figure S3. Effects of a HFD on KA‑induced hippocam‑
pal COX‑2 and iNOS expression. Western blot and quantification of COX‑2 
(A) and iNOS (C) in the hippocampus after KA treatment. Densitometry 
values for each protein were normalized to α‑tubulin or β‑actin and 
expressed as fold change relative to the ND group. Data are shown as 
mean ± SEM (n = 4 mice per group). *p < 0.05 versus ND. #p < 0.05 
versus HFD. (B) Representative images of COX‑2 immunostaining in the 
hippocampus of ND and HFD mice with or without KA treatment. Scale 
bar = 100 µm.
Additional file 5: Figure S4. Effects of HFD on KA‑induced ER stress. 
Western blot analysis of PERK and ATF4 (A), 4‑HNE (B), and NQO1 (C) in the 
hippocampus after KA treatment. Densitometry values for each protein 
were normalized to α–tubulin or β‑actin and expressed as fold change 
relative to the ND group. Data are shown as mean ± SEM (n = 4 mice per 
group). *p < 0.05 versus ND. #p < 0.05 versus HFD.
Additional file 6: Table S2. List of primary antibodies.
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